Ignite Creation Date:
2024-05-05 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00039585
Status:
COMPLETED
Last Update Posted:
2015-04-30
First Post:
2002-06-06
Brief Title:
Imatinib Mesylate in Treating Patients With Refractory or Relapsed Ovarian Epithelial Fallopian Tube or Primary Peritoneal Cancer or Ovarian Low Malignant Potential Tumor
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI